We are live on
!
Find out more
RS
R Squared Portfolio holdings
AUM
$182M
1-Year Est. Return
18.52%
This Fund
S&P 500
This Quarter
Est. Return
+0.01%
1 Year Est. Return
+18.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$103M
AUM Growth
–
Cap. Flow
+$107M
Cap. Flow
% of AUM
104.12%
Top 10 Holdings %
Top 10 Hldgs %
10.53%
Holding
1,571
New
1,571
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$2.59M |
| 2 |
FirstEnergy
FE
|
+$1.2M |
| 3 |
Eaton
ETN
|
+$1.08M |
| 4 |
Consolidated Edison
ED
|
+$1.06M |
| 5 |
Verizon
VZ
|
+$1M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.64% |
| 2 | Technology | 14.58% |
| 3 | Industrials | 13.88% |
| 4 | Consumer Discretionary | 12.94% |
| 5 | Healthcare | 11.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBLL
1226
CeriBell Inc
CBLL
$638M
| $7.5K | 0.01% |
+290
| New | +$7.9K |
|
1227
OraSure Technologies
OSUR
$261M
| $7.47K | 0.01% |
+2,070
| New | +$8.24K |
|
1228
Ultrapar
UGP
$6.95B
| $7.47K | 0.01% |
+2,840
| New | +$9.41K |
|
1229
Revolution Medicines
RVMD
$38.9B
| $7.44K | 0.01% |
+170
| New | +$8.58K |
|
1230
Leonardo DRS
DRS
$12.2B
| $7.43K | 0.01% |
+230
| New | +$7.47K |
|
|
MBX
1231
MBX Biosciences
MBX
$2.77B
| $7.37K | 0.01% |
+400
| New | +$8.53K |
|
1232
QuantumScape Corp
QS
$3.61B
| $7.32K | 0.01% |
+1,410
| New | +$7.4K |
|
1233
Shenandoah Telecom
SHEN
$651M
| $7.31K | 0.01% |
+580
| New | +$7.8K |
|
1234
Atlassian
TEAM
$21.7B
| $7.3K | 0.01% |
+30
| New | +$6.87K |
|
1235
Integra LifeSciences
IART
$1.46B
| $7.26K | 0.01% |
+320
| New | +$6.99K |
|
|
NVRO
1236
DELISTED
NEVRO CORP.
NVRO
| $7.22K | 0.01% |
+1,940
| New | +$8.96K |
|
1237
Astronics
ATRO
$3.5B
| $7.18K | 0.01% |
+540
| New | +$7.93K |
|
|
MRC
1238
DELISTED
MRC Global
MRC
| $7.16K | 0.01% |
+560
| New | +$7.33K |
|
1239
Televisa
TV
$1.49B
| $7.11K | 0.01% |
+4,230
| New | +$9.17K |
|
1240
Cogent Biosciences
COGT
$6.76B
| $7.1K | 0.01% |
+910
| New | +$9.07K |
|
1241
Kearny Financial
KRNY
$597M
| $7.08K | 0.01% |
+1,000
| New | +$7.52K |
|
1242
PACS Group
PACS
$7.13B
| $7.08K | 0.01% |
+540
| New | +$13.9K |
|
|
CSW
1243
CSW Industrials
CSW
$4.6B
| $7.06K | 0.01% |
+20
| New | +$7.78K |
|
1244
Avantor
AVTR
$7.48B
| $6.95K | 0.01% |
+330
| New | +$7.42K |
|
|
HOUS
1245
DELISTED
Anywhere Real Estate
HOUS
| $6.93K | 0.01% |
+2,101
| New | +$9.01K |
|
1246
Praxis Precision Medicines
PRAX
$8.7B
| $6.93K | 0.01% |
+90
| New | +$6.51K |
|
1247
Marqeta
MQ
$1.81B
| $6.86K | 0.01% |
+453
| New | +$7.95K |
|
1248
NovoCure
NVCR
$1.8B
| $6.85K | 0.01% |
+230
| New | +$4.87K |
|
1249
VirTra
VTSI
$34.1M
| $6.82K | 0.01% |
+1,010
| New | +$6.81K |
|
1250
Stewart Information Services
STC
$2.12B
| $6.75K | 0.01% |
+100
| New | +$7.15K |
|
Similar funds
NED
CFG
CFG
WCM
TFP
AFS
EMB
TCPG
R Squared's Q4 2024 Portfolio in Review
Q4 2024 is the first quarter with a 13F filing on record for R Squared, which disclosed 1,571 positions worth $103M. Its ten largest holdings account for 11% of the portfolio.
Its largest position is Linde: 5,681 shares worth $2.38M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, followed by Technology and Industrials.
- R Squared's largest Q4 2024 buy was Linde: 5,681 shares worth $2.38M.
- R Squared's ten largest holdings make up 11% of its $103M portfolio in Q4 2024.
- R Squared disclosed 1,571 positions in Q4 2024, its first 13F filing on record.
Based on R Squared's 13F filing for Q4 2024, filed 23 Jan 2025.